Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	60.33	-82.34	-207.55
Graham Fair Price	0.00	0.84	0.84
PEG	inf	0.00	0.16
Price/Book	-10.44	0.37	0.42
Price/Cash Flow	-10.44	4.92	5.50
Prices/Earnings	10.44	-8.60	-9.60
Price/Sales	-10.44	2.16	2.41
Price/FCF	-10.44	4.92	5.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.08	0.08
Operating Margin	0.00	-0.08	-0.08
ROA	0.00	< 0.005	< 0.005
ROE	-0.01	-0.01	0.00
ROIC	< 0.005	< 0.005	-68.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.58	0.63	-8.21
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.44	0.00	inf
EPS QOQ	0.59	0.00	inf
FCF QOQ	0.82	0.00	inf
Revenue QOQ	1.40	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	283.12	278.35	-1.68
Days Sales Outstanding (DSO)	28.40	27.35	-3.70
Inventory Turnover	0.32	0.32	1.71
Debt/Capitalization	0.70	0.49	-29.55
Quick Ratio	0.25	0.25	-0.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.71	1.71	0.00
Cash	0.58	0.58	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.13	0.13	0.00
Revenue	0.29	0.29	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.61	0.61	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-171.49	-51.76	69.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating